APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Beraprost Sodium

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Beraprost Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173969870320 December 2025191 pages

Choose your research edition.

Industry ResearchBeraprost Sodium Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Beraprost Sodium Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Beraprost Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beraprost Sodium Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Beraprost Sodium Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Beraprost Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Beraprost Sodium include Teva, Daiichi Sankyo Co Ltd, Yoshindo, Viatris, Toray, Taide Pharma, Shin Poong Pharmaceutical, Sawai Pharmaceutical and Ohara Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Beraprost Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Beraprost Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Beraprost Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Beraprost Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Beraprost Sodium Segment by Company

Teva

Daiichi Sankyo Co Ltd

Yoshindo

Viatris

Toray

Taide Pharma

Shin Poong Pharmaceutical

Sawai Pharmaceutical

Ohara Inc

Nihon Generic Co Ltd

Nichiiko

NABIQASIM INDUSTRIES

Lupin Laboratories

KYOUSOUMIRAI PHARM

Kyorin Holding

Kaken Pharmaceutical

Astellas Pharma

Alfresa Pharma

Beraprost Sodium Segment by Type

Tablet

Sustained Release Tablets

Beraprost Sodium Segment by Application

Hospital

Clinic

Beraprost Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beraprost Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beraprost Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beraprost Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Beraprost Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Beraprost Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Beraprost Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Beraprost Sodium Industry Trends Table 2. Beraprost Sodium Industry Drivers Table 3. Beraprost Sodium Industry Opportunities and Challenges Table 4. Beraprost Sodium Industry Restraints Table 5. Global Beraprost Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Beraprost Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Beraprost Sodium Sales by Manufacturers (k pcs) & (2021-2026) Table 8. Global Beraprost Sodium Sales Market Share by Manufacturers Table 9. Global Beraprost Sodium Average Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 10. Global Beraprost Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Beraprost Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Beraprost Sodium Manufacturers, Product Type & Application Table 13. Global Beraprost Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Beraprost Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Sustained Release Tablets Table 18. Global Beraprost Sodium Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Beraprost Sodium Sales by Type (2021-2026) & (k pcs) Table 20. Global Beraprost Sodium Sales by Type (2027-2032) & (k pcs) Table 21. Global Beraprost Sodium Sales Market Share by Type (2021-2026) Table 22. Global Beraprost Sodium Sales Market Share by Type (2027-2032) Table 23. Global Beraprost Sodium Revenue by Type 2021 VS 2025 VS 2032 (k pcs) Table 24. Global Beraprost Sodium Revenue by Type (2021-2026) & (k pcs) Table 25. Global Beraprost Sodium Revenue by Type (2027-2032) & (k pcs) Table 26. Global Beraprost Sodium Revenue Market Share by Type (2021-2026) Table 27. Global Beraprost Sodium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Beraprost Sodium Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 31. Global Beraprost Sodium Sales by Application (2021-2026) & (k pcs) Table 32. Global Beraprost Sodium Sales by Application (2027-2032) & (k pcs) Table 33. Global Beraprost Sodium Sales Market Share by Application (2021-2026) Table 34. Global Beraprost Sodium Sales Market Share by Application (2027-2032) Table 35. Global Beraprost Sodium Revenue by Application 2021 VS 2025 VS 2032 (k pcs) Table 36. Global Beraprost Sodium Revenue by Application (2021-2026) & (k pcs) Table 37. Global Beraprost Sodium Revenue by Application (2027-2032) & (k pcs) Table 38. Global Beraprost Sodium Revenue Market Share by Application (2021-2026) Table 39. Global Beraprost Sodium Revenue Market Share by Application (2027-2032) Table 40. Global Beraprost Sodium Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 41. Global Beraprost Sodium Sales by Region (2021-2026) & (k pcs) Table 42. Global Beraprost Sodium Sales Market Share by Region (2021-2026) Table 43. Global Beraprost Sodium Sales Forecasted by Region (2027-2032) & (k pcs) Table 44. Global Beraprost Sodium Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 46. North America Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 47. North America Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 48. Europe Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 49. Europe Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 50. Europe Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 51. Asia Pacific Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 52. Asia Pacific Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 53. Asia Pacific Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 54. South America, Middle East and Africa Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 55. South America, Middle East and Africa Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 56. South America, Middle East and Africa Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 57. Global Beraprost Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Beraprost Sodium Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Beraprost Sodium Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Beraprost Sodium Revenue Market Share by Region (2021-2026) Table 61. Global Beraprost Sodium Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Beraprost Sodium Product Portfolio Table 66. Teva Recent Development Table 67. Daiichi Sankyo Co Ltd Company Information Table 68. Daiichi Sankyo Co Ltd Business Overview Table 69. Daiichi Sankyo Co Ltd Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio Table 71. Daiichi Sankyo Co Ltd Recent Development Table 72. Yoshindo Company Information Table 73. Yoshindo Business Overview Table 74. Yoshindo Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Yoshindo Beraprost Sodium Product Portfolio Table 76. Yoshindo Recent Development Table 77. Viatris Company Information Table 78. Viatris Business Overview Table 79. Viatris Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Viatris Beraprost Sodium Product Portfolio Table 81. Viatris Recent Development Table 82. Toray Company Information Table 83. Toray Business Overview Table 84. Toray Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Toray Beraprost Sodium Product Portfolio Table 86. Toray Recent Development Table 87. Taide Pharma Company Information Table 88. Taide Pharma Business Overview Table 89. Taide Pharma Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Taide Pharma Beraprost Sodium Product Portfolio Table 91. Taide Pharma Recent Development Table 92. Shin Poong Pharmaceutical Company Information Table 93. Shin Poong Pharmaceutical Business Overview Table 94. Shin Poong Pharmaceutical Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio Table 96. Shin Poong Pharmaceutical Recent Development Table 97. Sawai Pharmaceutical Company Information Table 98. Sawai Pharmaceutical Business Overview Table 99. Sawai Pharmaceutical Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sawai Pharmaceutical Beraprost Sodium Product Portfolio Table 101. Sawai Pharmaceutical Recent Development Table 102. Ohara Inc Company Information Table 103. Ohara Inc Business Overview Table 104. Ohara Inc Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Ohara Inc Beraprost Sodium Product Portfolio Table 106. Ohara Inc Recent Development Table 107. Nihon Generic Co Ltd Company Information Table 108. Nihon Generic Co Ltd Business Overview Table 109. Nihon Generic Co Ltd Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Nihon Generic Co Ltd Beraprost Sodium Product Portfolio Table 111. Nihon Generic Co Ltd Recent Development Table 112. Nichiiko Company Information Table 113. Nichiiko Business Overview Table 114. Nichiiko Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Nichiiko Beraprost Sodium Product Portfolio Table 116. Nichiiko Recent Development Table 117. NABIQASIM INDUSTRIES Company Information Table 118. NABIQASIM INDUSTRIES Business Overview Table 119. NABIQASIM INDUSTRIES Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio Table 121. NABIQASIM INDUSTRIES Recent Development Table 122. Lupin Laboratories Company Information Table 123. Lupin Laboratories Business Overview Table 124. Lupin Laboratories Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Lupin Laboratories Beraprost Sodium Product Portfolio Table 126. Lupin Laboratories Recent Development Table 127. KYOUSOUMIRAI PHARM Company Information Table 128. KYOUSOUMIRAI PHARM Business Overview Table 129. KYOUSOUMIRAI PHARM Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio Table 131. KYOUSOUMIRAI PHARM Recent Development Table 132. Kyorin Holding Company Information Table 133. Kyorin Holding Business Overview Table 134. Kyorin Holding Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Kyorin Holding Beraprost Sodium Product Portfolio Table 136. Kyorin Holding Recent Development Table 137. Kaken Pharmaceutical Company Information Table 138. Kaken Pharmaceutical Business Overview Table 139. Kaken Pharmaceutical Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Kaken Pharmaceutical Beraprost Sodium Product Portfolio Table 141. Kaken Pharmaceutical Recent Development Table 142. Astellas Pharma Company Information Table 143. Astellas Pharma Business Overview Table 144. Astellas Pharma Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Astellas Pharma Beraprost Sodium Product Portfolio Table 146. Astellas Pharma Recent Development Table 147. Alfresa Pharma Company Information Table 148. Alfresa Pharma Business Overview Table 149. Alfresa Pharma Beraprost Sodium Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Alfresa Pharma Beraprost Sodium Product Portfolio Table 151. Alfresa Pharma Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Beraprost Sodium Distributors List Table 155. Beraprost Sodium Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Beraprost Sodium Product Image Figure 2. Global Beraprost Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Beraprost Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Beraprost Sodium Sales (2021-2032) & (k pcs) Figure 5. Global Beraprost Sodium Average Price (US$/pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Beraprost Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Sustained Release Tablets Image Figure 10. Global Beraprost Sodium Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 11. Global Beraprost Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Beraprost Sodium Sales Market Share by Type (2021-2032) Figure 13. Global Beraprost Sodium Revenue by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 14. Global Beraprost Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Beraprost Sodium Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Beraprost Sodium Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 19. Global Beraprost Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Beraprost Sodium Sales Market Share by Application (2021-2032) Figure 21. Global Beraprost Sodium Revenue by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Beraprost Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Beraprost Sodium Revenue Market Share by Application (2021-2032) Figure 24. North America Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 25. North America Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 26. U.S. Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 27. Canada Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 28. Mexico Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 29. Europe Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 30. Europe Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 31. Germany Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 32. France Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 33. U.K. Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 34. Italy Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 35. Netherlands Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 36. Asia Pacific Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 37. Asia Pacific Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 38. China Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 39. Japan Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 40. South Korea Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 41. Southeast Asia Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 42. India Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 43. Australia Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 44. South America, Middle East and Africa Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 45. South America, Middle East and Africa Beraprost Sodium Sales Market Share by Country (2021-2032) Figure 46. Brazil Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 47. South Africa Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 48. Saudi Arabia Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 49. Turkey Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 50. Argentina Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 51. UAE Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 52. Egypt Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 53. Chile Beraprost Sodium Sales and Growth Rate (2021-2032) & (k pcs) Figure 54. Global Beraprost Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Beraprost Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Beraprost Sodium Revenue (2021-2032) & (US$ Million) Figure 57. North America Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Beraprost Sodium Revenue (2021-2032) & (US$ Million) Figure 59. Europe Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Beraprost Sodium Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Beraprost Sodium Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Beraprost Sodium Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Beraprost Sodium Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Sustained Release Tablets
Applications
  • Hospital
  • Clinic
Companies covered
  • Teva
  • Daiichi Sankyo Co Ltd
  • Yoshindo
  • Viatris
  • Toray
  • Taide Pharma
  • Shin Poong Pharmaceutical
  • Sawai Pharmaceutical
  • Ohara Inc
  • Nihon Generic Co Ltd
  • Nichiiko
  • NABIQASIM INDUSTRIES
  • Lupin Laboratories
  • KYOUSOUMIRAI PHARM
  • Kyorin Holding
  • Kaken Pharmaceutical
  • Astellas Pharma
  • Alfresa Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Beraprost Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Beraprost Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Beraprost Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Beraprost Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Beraprost Sodium Market Dynamics
  1. 2.1 Beraprost Sodium Industry Trends
  2. 2.2 Beraprost Sodium Industry Drivers
  3. 2.3 Beraprost Sodium Industry Opportunities and Challenges
  4. 2.4 Beraprost Sodium Industry Restraints
3 Beraprost Sodium Market by Manufacturers
  1. 3.1 Global Beraprost Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Beraprost Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Beraprost Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Beraprost Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Beraprost Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Beraprost Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Beraprost Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Beraprost Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Beraprost Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Beraprost Sodium Tier 1, Tier 2, and Tier 3
4 Beraprost Sodium Market by Type
  1. 4.1 Beraprost Sodium Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Sustained Release Tablets
  4. 4.2 Global Beraprost Sodium Sales by Type
  5. 4.2.1 Global Beraprost Sodium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Beraprost Sodium Sales by Type (2021-2032)
  7. 4.2.3 Global Beraprost Sodium Sales Market Share by Type (2021-2032)
  8. 4.3 Global Beraprost Sodium Revenue by Type
  9. 4.3.1 Global Beraprost Sodium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Beraprost Sodium Revenue by Type (2021-2032)
  11. 4.3.3 Global Beraprost Sodium Revenue Market Share by Type (2021-2032)
5 Beraprost Sodium Market by Application
  1. 5.1 Beraprost Sodium Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Beraprost Sodium Sales by Application
  5. 5.2.1 Global Beraprost Sodium Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Beraprost Sodium Sales by Application (2021-2032)
  7. 5.2.3 Global Beraprost Sodium Sales Market Share by Application (2021-2032)
  8. 5.3 Global Beraprost Sodium Revenue by Application
  9. 5.3.1 Global Beraprost Sodium Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Beraprost Sodium Revenue by Application (2021-2032)
  11. 5.3.3 Global Beraprost Sodium Revenue Market Share by Application (2021-2032)
6 Global Beraprost Sodium Sales by Region
  1. 6.1 Global Beraprost Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Beraprost Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Beraprost Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Beraprost Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Beraprost Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Beraprost Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Beraprost Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Beraprost Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Beraprost Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Beraprost Sodium Revenue by Region
  1. 7.1 Global Beraprost Sodium Revenue by Region
  2. 7.1.1 Global Beraprost Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Beraprost Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Beraprost Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Beraprost Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Beraprost Sodium Revenue (2021-2032)
  8. 7.2.2 North America Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Beraprost Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Beraprost Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Beraprost Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Beraprost Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Beraprost Sodium Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Daiichi Sankyo Co Ltd
  8. 8.2.1 Daiichi Sankyo Co Ltd Company Information
  9. 8.2.2 Daiichi Sankyo Co Ltd Business Overview
  10. 8.2.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
  12. 8.2.5 Daiichi Sankyo Co Ltd Recent Developments
  13. 8.3 Yoshindo
  14. 8.3.1 Yoshindo Company Information
  15. 8.3.2 Yoshindo Business Overview
  16. 8.3.3 Yoshindo Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Yoshindo Beraprost Sodium Product Portfolio
  18. 8.3.5 Yoshindo Recent Developments
  19. 8.4 Viatris
  20. 8.4.1 Viatris Company Information
  21. 8.4.2 Viatris Business Overview
  22. 8.4.3 Viatris Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Viatris Beraprost Sodium Product Portfolio
  24. 8.4.5 Viatris Recent Developments
  25. 8.5 Toray
  26. 8.5.1 Toray Company Information
  27. 8.5.2 Toray Business Overview
  28. 8.5.3 Toray Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Toray Beraprost Sodium Product Portfolio
  30. 8.5.5 Toray Recent Developments
  31. 8.6 Taide Pharma
  32. 8.6.1 Taide Pharma Company Information
  33. 8.6.2 Taide Pharma Business Overview
  34. 8.6.3 Taide Pharma Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Taide Pharma Beraprost Sodium Product Portfolio
  36. 8.6.5 Taide Pharma Recent Developments
  37. 8.7 Shin Poong Pharmaceutical
  38. 8.7.1 Shin Poong Pharmaceutical Company Information
  39. 8.7.2 Shin Poong Pharmaceutical Business Overview
  40. 8.7.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
  42. 8.7.5 Shin Poong Pharmaceutical Recent Developments
  43. 8.8 Sawai Pharmaceutical
  44. 8.8.1 Sawai Pharmaceutical Company Information
  45. 8.8.2 Sawai Pharmaceutical Business Overview
  46. 8.8.3 Sawai Pharmaceutical Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sawai Pharmaceutical Beraprost Sodium Product Portfolio
  48. 8.8.5 Sawai Pharmaceutical Recent Developments
  49. 8.9 Ohara Inc
  50. 8.9.1 Ohara Inc Company Information
  51. 8.9.2 Ohara Inc Business Overview
  52. 8.9.3 Ohara Inc Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ohara Inc Beraprost Sodium Product Portfolio
  54. 8.9.5 Ohara Inc Recent Developments
  55. 8.10 Nihon Generic Co Ltd
  56. 8.10.1 Nihon Generic Co Ltd Company Information
  57. 8.10.2 Nihon Generic Co Ltd Business Overview
  58. 8.10.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
  60. 8.10.5 Nihon Generic Co Ltd Recent Developments
  61. 8.11 Nichiiko
  62. 8.11.1 Nichiiko Company Information
  63. 8.11.2 Nichiiko Business Overview
  64. 8.11.3 Nichiiko Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nichiiko Beraprost Sodium Product Portfolio
  66. 8.11.5 Nichiiko Recent Developments
  67. 8.12 NABIQASIM INDUSTRIES
  68. 8.12.1 NABIQASIM INDUSTRIES Company Information
  69. 8.12.2 NABIQASIM INDUSTRIES Business Overview
  70. 8.12.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
  72. 8.12.5 NABIQASIM INDUSTRIES Recent Developments
  73. 8.13 Lupin Laboratories
  74. 8.13.1 Lupin Laboratories Company Information
  75. 8.13.2 Lupin Laboratories Business Overview
  76. 8.13.3 Lupin Laboratories Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Lupin Laboratories Beraprost Sodium Product Portfolio
  78. 8.13.5 Lupin Laboratories Recent Developments
  79. 8.14 KYOUSOUMIRAI PHARM
  80. 8.14.1 KYOUSOUMIRAI PHARM Company Information
  81. 8.14.2 KYOUSOUMIRAI PHARM Business Overview
  82. 8.14.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
  84. 8.14.5 KYOUSOUMIRAI PHARM Recent Developments
  85. 8.15 Kyorin Holding
  86. 8.15.1 Kyorin Holding Company Information
  87. 8.15.2 Kyorin Holding Business Overview
  88. 8.15.3 Kyorin Holding Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Kyorin Holding Beraprost Sodium Product Portfolio
  90. 8.15.5 Kyorin Holding Recent Developments
  91. 8.16 Kaken Pharmaceutical
  92. 8.16.1 Kaken Pharmaceutical Company Information
  93. 8.16.2 Kaken Pharmaceutical Business Overview
  94. 8.16.3 Kaken Pharmaceutical Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kaken Pharmaceutical Beraprost Sodium Product Portfolio
  96. 8.16.5 Kaken Pharmaceutical Recent Developments
  97. 8.17 Astellas Pharma
  98. 8.17.1 Astellas Pharma Company Information
  99. 8.17.2 Astellas Pharma Business Overview
  100. 8.17.3 Astellas Pharma Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Astellas Pharma Beraprost Sodium Product Portfolio
  102. 8.17.5 Astellas Pharma Recent Developments
  103. 8.18 Alfresa Pharma
  104. 8.18.1 Alfresa Pharma Company Information
  105. 8.18.2 Alfresa Pharma Business Overview
  106. 8.18.3 Alfresa Pharma Beraprost Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Alfresa Pharma Beraprost Sodium Product Portfolio
  108. 8.18.5 Alfresa Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Beraprost Sodium Value Chain Analysis
  2. 9.1.1 Beraprost Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Beraprost Sodium Production Mode & Process
  6. 9.2 Beraprost Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Beraprost Sodium Distributors
  9. 9.2.3 Beraprost Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst